|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qiu Y, Liu Q, Chen G, Wang W, Peng K, Xiao
W and Yang H: Outcome of rectal cancer surgery in obese and
nonobese patients: A meta-analysis. World J Surg Oncol. 14:232016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hammond WA, Swaika A and Mody K:
Pharmacologic resistance in colorectal cancer: A review. Ther Adv
Med Oncol. 8:57–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ebbesen KK, Kjems J and Hansen TB:
Circular RNAs: Identification, biogenesis and function. Biochim
Biophys Acta. 1859:163–168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z
and Sharpless NE: Expression of linear and novel circular forms of
an INK4/ARF-associated non-coding RNA correlates with
atherosclerosis risk. PLoS Genet. 6:e10012332010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li P, Chen S, Chen H, Mo X, Li T, Shao Y,
Xiao B and Guo J: Using circular RNA as a novel type of biomarker
in the screening of gastric cancer. Clin Chim Acta. 444:132–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bian L, Zhi X, Ma L, Zhang J, Chen P, Sun
S, Li J, Sun Y and Qin J: Hsa_circRNA_103809 regulated the cell
proliferation and migration in colorectal cancer via
miR-532-3p/FOXO4 axis. Biochem Biophys Res Commun. 505:346–352.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fang G, Ye BL, Hu BR, Ruan XJ and Shi YX:
CircRNA_100290 promotes colorectal cancer progression through
miR-516b-induced downregulation of FZD4 expression and
Wnt/β-catenin signaling. Biochem Biophys Res Commun. 504:184–189.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li R, Wu B, Xia J, Ye L and Yang X:
Circular RNA hsa_circRNA_102958 promotes tumorigenesis of
colorectal cancer via miR-585/CDC25B axis. Cancer Manag Res.
11:6887–6893. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan W, Peng S, Wang J, Wei C, Ye Z, Wang
Y, Wang M, Xu H, Jiang S, Sun D, et al: Identification and
characterization of circRNAs as competing endogenous RNAs for
miRNA-mRNA in colorectal cancer. PeerJ. 7:e76022019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei WT, Nian XX, Wang SY, Jiao HL, Wang
YX, Xiao ZY, Yang RW, Ding YQ, Ye YP and Liao WT: miR-422a inhibits
cell proliferation in colorectal cancer by targeting AKT1 and
MAPK1. Cancer Cell Int. 17:912017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tong F, Ying Y, Pan H, Zhao W, Li H and
Zhan X: MicroRNA-466 (miR-466) functions as a tumor suppressor and
prognostic factor in colorectal cancer (CRC). Bosn J Basic Med Sci.
18:252–259. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen M, Li D, Gong N, Wu H, Su C, Xie C,
Xiang H, Lin C and Li X: miR-133b down-regulates ABCC1 and enhances
the sensitivity of CRC to anti-tumor drugs. Oncotarget.
8:52983–52994. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Xu X, Pan B, Zeng K, Xu M, Liu X,
He B, Pan Y, Sun H and Wang S: miR-150-5p suppresses tumor
progression by targeting VEGFA in colorectal cancer. Aging (Albany
NY). 10:3421–3437. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu XX, Xu XN, He BS, Sun HL, Xu T, Liu XX,
Chen XX, Zeng KX, Wang SK and Pan YQ: microRNA-485-5p Functions as
a tumor suppressor in colorectal cancer cells by targeting CD147. J
Cancer. 9:2603–2611. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Xu J, Yan X, Jin K, Li W and Zhang
R: MicroRNA-485 plays tumour-suppressive roles in colorectal cancer
by directly targeting GAB2. Oncol Rep. 40:554–564. 2018.PubMed/NCBI
|
|
17
|
Hayles J, Beach D, Durkacz B and Nurse P:
The fission yeast cell cycle control gene cdc2: Isolation of a
sequence suc1 that suppresses cdc2 mutant function. Mol Gen Genet.
202:291–293. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee EK, Kim DG, Kim JS and Yoon Y:
Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by
supporting NF-KB-dependent expression of interleukin-8. Cancer Res.
71:6827–6835. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hwang JS, Jeong EJ, Choi J, Lee YJ, Jung
E, Kim SK, Min JK, Han TS and Kim JS: MicroRNA-1258 inhibits the
proliferation and migration of human colorectal cancer cells
through suppressing CKS1B expression. Genes (Basel). 10:9122019.
View Article : Google Scholar
|
|
20
|
Zhao SJ, Shen YF, Li Q, He YJ, Zhang YK,
Hu LP, Jiang YQ, Xu NW, Wang YJ, Li J, et al: SLIT2/ROBO1 axis
contributes to the Warburg effect in osteosarcoma through
activation of SRC/ERK/c-MYC/PFKFB2 pathway. Cell Death Dis.
9:3902018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shida D, Kanemitsu Y, Hamaguchi T and
Shimada Y: Introducing the eighth edition of the
tumor-node-metastasis classification as relevant to colorectal
cancer, anal cancer and appendiceal cancer: A comparison study with
the seventh edition of the tumor-node-metastasis and the Japanese
classification of colorectal, appendiceal, and anal carcinoma. Jpn
J Clin Oncol. 49:321–328. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cantor JR and Sabatini DM: Cancer cell
metabolism: One hallmark, many faces. Cancer Discov. 2:881–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin YD, Ren YR, Gao YX, Zhang L and Ding
Z: Hsa_circ_0005075 predicts a poor prognosis and acts as an
oncogene in colorectal cancer via activating Wnt/β-catenin pathway.
Eur Rev Med Pharmacol Sci. 23:3311–3319. 2019.PubMed/NCBI
|
|
24
|
Lu C, Jiang W, Hui B, Rong D, Fu K, Dong
C, Tang W and Cao H: The circ_0021977/miR-10b-5p/P21 and P53
regulatory axis suppresses proliferation, migration, and invasion
in colorectal cancer. J Cell Physiol. 235:2273–2285. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu CL, Sha X, Wang Y, Li J, Zhang MY, Guo
ZY, Sun SA and He JD: Circular RNA hsa_circ_0007142 is upregulated
and targets miR-103a-2-5p in colorectal cancer. J Oncol.
2019:98368192019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu L, Xia J, Yang J, Shi Y, Xia H, Xiang X
and Yu X: Circ-ZNF609 promotes migration of colorectal cancer by
inhibiting Gli1 expression via microRNA-150. J BUON. 23:1343–1349.
2018.PubMed/NCBI
|
|
27
|
Liu Z, Pan HM, Xin L, Zhang Y, Zhang WM,
Cao P and Xu HW: Circ-ZNF609 promotes carcinogenesis of gastric
cancer cells by inhibiting miRNA-145-5p expression. Eur Rev Med
Pharmacol Sci. 23:9411–9417. 2019.PubMed/NCBI
|
|
28
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg's contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Q, Wei P, Wu J, Zhang M, Li G, Li Y, Xu
Y, Li X, Xie D, Cai S, et al: The FOXC1/FBP1 signaling axis
promotes colorectal cancer proliferation by enhancing the Warburg
effect. Oncogene. 38:483–496. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang M, Liu T, Sun H, Weng W, Zhang Q,
Liu C, Han Y and Sheng W: Pim1 supports human colorectal cancer
growth during glucose deprivation by enhancing the Warburg effect.
Cancer Sci. 109:1468–1479. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang M, Cai WR, Meng R, Chi JR, Li YR,
Chen AX, Yu Y and Cao XC: miR-485-5p suppresses breast cancer
progression and chemosensitivity by targeting survivin. Biochem
Biophys Res Commun. 501:48–54. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kang M, Ren MP, Zhao L, Li CP and Deng MM:
miR-485-5p acts as a negative regulator in gastric cancer
progression by targeting flotillin-1. Am J Transl Res. 7:2212–2222.
2015.PubMed/NCBI
|
